MYCOLab Ai Logo - gold and army green

If psychedelics heal, how do they do it?

Summary

Psychedelic drugs like MDMA and magic mushrooms are showing remarkable promise in treating serious mental health conditions like PTSD and depression, with clinical trials demonstrating higher success rates than traditional therapy alone. However, scientists still don’t fully understand how these drugs work at the molecular and brain level, or whether the hallucinations they produce are necessary for healing. Researchers are investigating whether modified versions without hallucinations could provide the same benefits while being easier to administer, while also exploring how individual factors and treatment environment affect outcomes.

Background

Psychedelics such as MDMA, psilocybin, LSD, and DMT are increasingly showing promise in clinical trials for treating difficult mental health conditions including PTSD, depression, and substance abuse disorders. Despite clinical successes, the underlying mechanisms of how these drugs produce therapeutic effects remain poorly understood. Understanding these mechanisms could lead to more effective treatments and improved patient outcomes.

Objective

To examine current research exploring the molecular, neurobiological, and whole-brain mechanisms by which psychedelics produce therapeutic effects in mental health treatment. The paper investigates whether the psychedelic experience itself is necessary for healing and explores how individual differences and environmental factors influence treatment outcomes.

Results

Research suggests psychedelics activate serotonin 5-HT2A receptors, causing rapid neuronal branching in the prefrontal cortex and temporarily reorganizing brain hierarchies. Studies show correlations between mystical experience intensity and treatment outcomes, though causality remains unclear. Evidence indicates psychedelics improve cognitive flexibility and may reduce pathological effort-avoidance behaviors, with effects persisting weeks after single doses.

Conclusion

While promising clinical results demonstrate psychedelic efficacy, fundamental questions remain unanswered about mechanisms, the necessity of hallucinations for healing, individual response variability, and optimal treatment conditions. Future research must address methodological limitations, explore personalized medicine approaches, and clarify relationships between molecular effects, neuroplasticity, and long-term therapeutic benefits.
  • Published in:Proceedings of the National Academy of Sciences U.S.A.,
  • Study Type:Review,
  • Source: PMID: 38170743, DOI: 10.1073/pnas.2321906121
Scroll to Top